Microbiome manipulation modifies sex-specific risk for autoimmunity

Gut Microbes

Volumn 5, Issue 4, 2014, Pages 485-493

  Markle, Janet Gm ^a,b   Frank, Daniel N ^c   Adeli, Khosrow ^a,b   Von Bergen, Martin ^d,e   Danska, Jayne S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF COLORADO   (United States)

^d HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^e AALBORG UNIVERSITY   (Denmark)

Author keywords

Immune response to microbiome; Metabolome; Mouse models of autoimmunity; Sex bias in disease; Steroid hormones; Type 1 diabetes

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; TESTOSTERONE;

ARTICLE; AUTOIMMUNE DISEASE; FEMALE; GENDER BIAS; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HLA SYSTEM; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MICROBIOME; MOUSE; NONHUMAN; PHENOTYPE; RISK FACTOR; SEQUENCE ANALYSIS; T LYMPHOCYTE; ANIMAL; AUTOIMMUNITY; BIOTA; BLOOD; GASTROINTESTINAL TRACT; MICROBIOLOGY; NONOBESE DIABETIC MOUSE; RISK ASSESSMENT;

ANIMALS; AUTOIMMUNITY; BIOTA; FEMALE; GASTROINTESTINAL TRACT; HUMANS; MALE; MICE, INBRED NOD; RISK ASSESSMENT; TESTOSTERONE;

EID: 84920952610     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.29795     Document Type: Article

References (85)

1. Markle JGM, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS. Sex differences in the gut microbiome drive hormonedependent regulation of autoimmunity. Science 2013; 339:1084-8 PMID:23328391; http://dx.doi.org/10.1126/science.1233521
2. Atkinson MA. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb Perspect Med 2012; 2 PMID:23125199; http://dx.doi.org/10.1101/cshperspect.a007641
3. Hakonarson H, Grant SF, Bradfield JP, Marchand L, Kim CE, Glessner JT, Grabs R, Casalunovo T, Taback SP, Frackelton EC, et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007; 448:591-4 PMID:17632545; http://dx.doi.org/10.1038/nature06010
4. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009; 41:703-7 PMID:19430480; http://dx.doi.org/10.1038/ng.381
5. Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K, Plagnol V, Bailey R, Nejentsev S, Field SF, Payne F, et al.; Genetics of Type 1 Diabetes in Finland; Wellcome Trust Case Control Consortium. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007; 39:857-64 PMID:17554260; http://dx.doi.org/10.1038/ng2068
6. Cooper JD, Smyth DJ, Smiles AM, Plagnol V, Walker NM, Allen JE, Downes K, Barrett JC, Healy BC, Mychaleckyj JC, et al. Meta-analysis of genomewide association study data identifies additional type 1 diabetes risk loci. Nat Genet 2008; 40:1399-401 PMID:18978792; http://dx.doi.org/10.1038/ng.249
7. McDevitt H. Closing in on type 1 diabetes. N Engl J Med 2001; 345:1060-1 PMID:11586961; http://dx.doi.org/10.1056/NEJM200110043451411
8. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987; 329:599-604 PMID:3309680; http://dx.doi.org/10.1038/329599a0
9. Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. [published online EpubApr]. Diabetes 2003; 52:1052-5 PMID:12663480; http://dx.doi.org/10.2337/diabetes.52.4.1052
10. Guttmann A, Nakhla M, Henderson M, To T, Daneman D, Cauch-Dudek K, Wang X, Lam K, Hux J. Validation of a health administrative data algorithm for assessing the epidemiology of diabetes in Canadian children. Pediatr Diabetes 2010; 11:122-8 PMID:19500278; http://dx.doi.org/10.1111/j.1399-5448.2009.00539.x
11. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009; 373:2027-33 PMID:19481249; http://dx.doi.org/10.1016/S0140-6736(09)60568-7
12. Soltesz G, Patterson CC, Dahlquist G; EURODIAB Study Group. Worldwide childhood type 1 diabetes incidence--what can we learn from epidemiology? Pediatr Diabetes 2007; 8(Suppl 6):6-14 PMID:17727380; http://dx.doi.org/10.1111/j.1399-5448.2007.00280.x
13. Schmidt D, Verdaguer J, Averill N, Santamaria P. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J Exp Med 1997; 186:1059-75 PMID:9314555; http://dx.doi.org/10.1084/jem.186.7.1059
14. Sgouroudis E, Albanese A, Piccirillo CA. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice. J Immunol 2008; 181:6283-92 PMID:18941219; http://dx.doi.org/10.4049/jimmunol.181.9.6283
15. Chistiakov DA, Voronova NV, Chistiakov PA. The crucial role of IL-2/IL-2RA-mediated immune regulation in the pathogenesis of type 1 diabetes, an evidence coming from genetic and animal model studies. Immunol Lett 2008; 118:1-5 PMID:18417224; http://dx.doi.org/10.1016/j.imlet.2008.03.002
16. Yamanouchi J, Rainbow D, Serra P, Howlett S, Hunter K, Garner VE, Gonzalez-Munoz A, Clark J, Veijola R, Cubbon R, et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 2007; 39:329-37 PMID:17277778; http://dx.doi.org/10.1038/ng1958
17. Wicker LS, Moule CL, Fraser H, Penha-Goncalves C, Rainbow D, Garner VE, Chamberlain G, Hunter K, Howlett S, Clark J, et al. Natural genetic variants influencing type 1 diabetes in humans and in the NOD mouse. Novartis Found Symp 2005; 267:57-65, discussion 65-75 PMID:15999801; http://dx.doi.org/10.1002/047002139X.ch6
18. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev 2003; 2:119-25 PMID:12848952; http://dx.doi.org/10.1016/S1568-9972(03)00006-5
19. Whitacre CC, Reingold SC, O’Looney PA. A gender gap in autoimmunity. Science 1999; 283:1277-8 PMID:10084932; http://dx.doi.org/10.1126/science.283.5406.1277
20. Scobie HM, Wigelsworth DJ, Marlett JM, Thomas D, Rainey GJ, Lacy DB, Manchester M, Collier RJ, Young JA. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo. PLoS Pathog 2006; 2:e111 PMID:17054395; http://dx.doi.org/10.1371/journal.ppat.0020111
21. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001; 2:777-80 PMID:11526384; http://dx.doi.org/10.1038/ni0901-777
22. Ober C, Loisel DA, Gilad Y. Sex-specific genetic architecture of human disease. Nat Rev Genet 2008; 9:911-22 PMID:19002143; http://dx.doi.org/10.1038/nrg2415
23. Gale CR, Martyn CN. Migrant studies in multiple sclerosis. [published online EpubNov-Dec ]. Prog Neurobiol 1995; 47:425-48 PMID:8966212; http://dx.doi.org/10.1016/0301-0082(95)00033-X
24. Bodansky HJ, Staines A, Stephenson C, Haigh D, Cartwright R. Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. BMJ 1992; 304:1020-2 PMID:1586783; http://dx.doi.org/10.1136/bmj.304.6833.1020
25. Patterson CC, Carson DJ, Hadden DR; Northern Ireland Diabetes Study Group. Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most household crowding. [published online EpubSep]. Diabetologia 1996; 39:1063-9 PMID:8877290; http://dx.doi.org/10.1007/BF00400655
26. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347:911-20 PMID:12239261; http://dx.doi.org/10.1056/NEJMra020100
27. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486:222-7 PMID:22699611
28. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, Angenent LT, Ley RE. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4578-85 PMID:20668239; http://dx.doi.org/10.1073/pnas.1000081107
29. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5:e177 PMID:17594176; http://dx.doi.org/10.1371/journal.pbio.0050177
30. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489:220-30 PMID:22972295; http://dx.doi.org/10.1038/nature11550
31. Penders J, Stobberingh EE, van den Brandt PA, Thijs C. The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007; 62:1223-36 PMID:17711557; http://dx.doi.org/10.1111/j.1398-9995.2007.01462.x
32. Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, McCoy KD, Macpherson AJ. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011; 34:794-806 PMID:21596591; http://dx.doi.org/10.1016/j.immuni.2011.03.021
33. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10:159-69 PMID:20182457; http://dx.doi.org/10.1038/nri2710
34. Kolb H, Burkart V, Appels B, Hanenberg H, Kantwerk-Funke G, Kiesel U, Funda J, Schraermeyer U, Kolb-Bachofen V. Essential contribution of macrophages to islet cell destruction in vivo and in vitro. [published online EpubApr ]. J Autoimmun 1990; 3(Suppl 1):117-20 PMID:2140261; http://dx.doi.org/10.1016/S0896-8411(09)90020-8
35. Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. [published online EpubMay ]. Diabetes 1994; 43:667-75 PMID:8168644; http://dx.doi.org/10.2337/diab.43.5.667
36. Reddy S, Wu D, Swinney C, Elliott RB. Immunohistochemical analyses of pancreatic macrophages and CD4 and CD8 T cell subsets prior to and following diabetes in the NOD mouse. [published online EpubJul ]. Pancreas 1995; 11:16-25 PMID:7667242; http://dx.doi.org/10.1097/00006676-199507000-00002
37. Fox CJ, Danska JS. Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation. [published online EpubMar ]. Diabetes 1998; 47:331-8 PMID:9519736; http://dx.doi.org/10.2337/diabetes.47.3.331
38. Fox CJ, Paterson AD, Mortin-Toth SM, Danska JS. Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis. Am J Hum Genet 2000; 67:67-81 PMID:10848492; http://dx.doi.org/10.1086/302995
39. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331:337-41 PMID:21205640; http://dx.doi.org/10.1126/science.1198469
40. Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, Glickman JN, Siebert R, Baron RM, Kasper DL, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336:489-93 PMID:22442383; http://dx.doi.org/10.1126/science.1219328
41. Makino S, Kunimoto K, Muraoka Y, Katagiri K. Effect of castration on the appearance of diabetes in NOD mouse. [published online EpubApr]. Jikken Dobutsu 1981; 30:137-40 PMID:7286067
42. Fox HS. Androgen treatment prevents diabetes in nonobese diabetic mice. J Exp Med 1992; 175:1409-12 PMID:1569406; http://dx.doi.org/10.1084/jem.175.5.1409
43. Bebo BF Jr., Schuster JC, Vandenbark AA, Offner H. Gender differences in experimental autoimmune encephalomyelitis develop during the induction of the immune response to encephalitogenic peptides. J Neurosci Res 1998; 52:420-6 PMID:9589386; http://dx.doi.org/10.1002/(SICI)1097-4547(19980515)52:4<420::AID-JNR5>3.0.CO;2-B
44. Voskuhl RR, Pitchekian-Halabi H, MacKenzie-Graham A, McFarland HF, Raine CS. Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann Neurol 1996; 39:724-33 PMID:8651644; http://dx.doi.org/10.1002/ana.410390608
45. Ahmed SA, Penhale WJ. The influence of testosterone on the development of autoimmune thyroiditis in thymectomized and irradiated rats. [published online EpubMay]. Clin Exp Immunol 1982; 48:367-74 PMID:7049452
46. Harbuz MS, Perveen-Gill Z, Lightman SL, Jessop DS. A protective role for testosterone in adjuvantinduced arthritis. [published online EpubDec]. Br J Rheumatol 1995; 34:1117-22 PMID:8608351; http://dx.doi.org/10.1093/rheumatology/34.12.1117
47. Philipp B. Bacterial degradation of bile salts. Appl Microbiol Biotechnol 2011; 89:903-15; http://dx.doi.org/10.1007/s00253-010-2998-0PMID:21088832
48. Poutahidis T, Springer A, Levkovich T, Qi P, Varian BJ, Lakritz JR, Ibrahim YM, Chatzigiagkos A, Alm EJ, Erdman SE. Probiotic microbes sustain youthful serum testosterone levels and testicular size in aging mice. PLoS One 2014; 9:e84877; http://dx.doi.org/10.1371/journal.pone.0084877PMID:24392159
49. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Bäckhed F, Mithieux G. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014; 156:84-96 PMID:24412651; http://dx.doi.org/10.1016/j.cell.2013.12.016
50. Rainey GJ, Wigelsworth DJ, Ryan PL, Scobie HM, Collier RJ, Young JA. Receptor-specific requirements for anthrax toxin delivery into cells. Proc Natl Acad Sci U S A 2005; 102:13278-83 PMID:16141341; http://dx.doi.org/10.1073/pnas.0505865102
51. Butterworth M, McClellan B, Allansmith M. Influence of sex in immunoglobulin levels. Nature 1967; 214:1224-5 PMID:4169229; http://dx.doi.org/10.1038/2141224a0
52. Petri M. Systemic lupus erythematosus and pregnancy. [published online EpubFeb ]. Rheum Dis Clin North Am 1994; 20:87-118 PMID:8153405
53. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T; Pregnancy in Multiple Sclerosis Group. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998; 339:285-91 PMID:9682040; http://dx.doi.org/10.1056/NEJM199807303390501
54. Nelson JL, Ostensen M. Pregnancy and rheumatoid arthritis. [published online EpubFeb]. Rheum Dis Clin North Am 1997; 23:195-212 PMID:9031383; http://dx.doi.org/10.1016/S0889-857X(05)70323-9
55. Cutolo M, Villaggio B, Craviotto C, Pizzorni C, Seriolo B, Sulli A. Sex hormones and rheumatoid arthritis. Autoimmun Rev 2002; 1:284-9 PMID:12848982; http://dx.doi.org/10.1016/S1568-9972(02)00064-2
56. Weinshenker BG. Natural history of multiple sclerosis. Ann Neurol 1994; 36(Suppl):S6-11 PMID:8017890; http://dx.doi.org/10.1002/ana.410360704
57. Wei T, Lightman SL. The neuroendocrine axis in patients with multiple sclerosis. [published online EpubJun]. Brain 1997; 120:1067-76 PMID:9217689; http://dx.doi.org/10.1093/brain/120.6.1067
58. Doran MF, Pond GR, Crowson CS, O’Fallon WM, Gabriel SE. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002; 46:625-31 PMID:11920397; http://dx.doi.org/10.1002/art.509
59. Harjutsalo V, Lammi N, Karvonen M, Groop PH. Age at onset of type 1 diabetes in parents and recurrence risk in offspring. Diabetes 2010; 59:210-4 PMID:19833881; http://dx.doi.org/10.2337/db09-0344
60. Williams AJ, Norcross AJ, Dix RJ, Gillespie KM, Gale EA, Bingley PJ. The prevalence of insulin autoantibodies at the onset of Type 1 diabetes is higher in males than females during adolescence. Diabetologia 2003; 46:1354-6 PMID:13680123; http://dx.doi.org/10.1007/s00125-003-1197-2
61. Biddle A. Lucy Stewart, Jeffrey Blanchard, Susan Leschine, Untangling the Genetic Basis of Fibrolytic Specialization by Lachnospiraceae and Ruminococcaceae in Diverse Gut Communities. Diversity 2013; 5:627-40; http://dx.doi.org/10.3390/d5030627
62. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504:451-5 PMID:24226773; http://dx.doi.org/10.1038/nature12726
63. Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol 2013; 14:676-84 PMID:23778795; http://dx.doi.org/10.1038/ni.2640
64. Donohoe DR, Garge N, Zhang X, Sun W, O’Connell TM, Bunger MK, Bultman SJ. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 2011; 13:517-26 PMID:21531334; http://dx.doi.org/10.1016/j.cmet.2011.02.018
65. Rossjohn J, Pellicci DG, Patel O, Gapin L, Godfrey DI. Recognition of CD1d-restricted antigens by natural killer T cells. Nat Rev Immunol 2012; 12:845-57 PMID:23154222; http://dx.doi.org/10.1038/nri3328
66. An D, Oh SF, Olszak T, Neves JF, Avci FY, Erturk-Hasdemir D, Lu X, Zeissig S, Blumberg RS, Kasper DL. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell 2014; 156:123-33 PMID:24439373; http://dx.doi.org/10.1016/j.cell.2013.11.042
67. Salton MR. Bacterial membranes. [published online EpubMay ]. CRC Crit Rev Microbiol 1971; 1:161-97 PMID:4114945; http://dx.doi.org/10.3109/10408417109104480
68. Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, Casella G, Drew JC, Ilonen J, Knip M, et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 2011; 6:e25792; http://dx.doi.org/10.1371/journal.pone.0025792PMID:22043294
69. Frank DN, Zhu W, Sartor RB, Li E. Investigating the biological and clinical significance of human dysbioses. Trends Microbiol 2011; 19:427-34 PMID:21775143; http://dx.doi.org/10.1016/j.tim.2011.06.005
70. Brugman S, Klatter FA, Visser JT, Wildeboer-Veloo AC, Harmsen HJ, Rozing J, Bos NA. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes? Diabetologia 2006; 49:2105-8 PMID:16816951; http://dx.doi.org/10.1007/s00125-006-0334-0
71. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008; 455:1109-13 PMID:18806780; http://dx.doi.org/10.1038/nature07336
72. Patrick C, Wang GS, Lefebvre DE, Crookshank JA, Sonier B, Eberhard C, Mojibian M, Kennedy CR, Brooks SP, Kalmokoff ML, et al. Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial Peptide. Diabetes 2013; 62:2036-47 PMID:23349499; http://dx.doi.org/10.2337/db12-1243
73. de Goffau MC, Luopajärvi K, Knip M, Ilonen J, Ruohtula T, Härkönen T, Orivuori L, Hakala S, Welling GW, Harmsen HJ, et al. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes 2013; 62:1238-44 PMID:23274889; http://dx.doi.org/10.2337/db12-0526
74. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105:16731-6 PMID:18936492; http://dx.doi.org/10.1073/pnas.0804812105
75. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104:13780-5 PMID:17699621; http://dx.doi.org/10.1073/pnas.0706625104
76. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Doré J. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009; 15:1183-9 PMID:19235886; http://dx.doi.org/10.1002/ibd.20903
77. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53:994-1002 PMID:22002980; http://dx.doi.org/10.1093/cid/cir632
78. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107:761-7 PMID:22290405; http://dx.doi.org/10.1038/ajg.2011.482
79. van Nood E, Dijkgraaf MG, Keller JJ. Duodenal infusion of feces for recurrent Clostridium difficile. N Engl J Med 2013; 368:2145 PMID:23718168; http://dx.doi.org/10.1056/NEJMoa1205037
80. McDonald JA, Schroeter K, Fuentes S, Heikamp-Dejong I, Khursigara CM, de Vos WM, Allen-Vercoe E. Evaluation of microbial community reproducibility, stability and composition in a human distal gut chemostat model. J Microbiol Methods 2013; 95:167-74 PMID:23994646; http://dx.doi.org/10.1016/j.mimet.2013.08.008
81. Petrof EO, Claud EC, Gloor GB, Allen-Vercoe E. Microbial ecosystems therapeutics: a new paradigm in medicine? Benef Microbes 2013; 4:53-65 PMID:23257018; http://dx.doi.org/10.3920/BM2012.0039
82. Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, Bluestone JA, Eisenbarth GS, Mathis D, Rossini AA, Campbell SE, et al. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 2005; 23:115-26 PMID:16111631; http://dx.doi.org/10.1016/j.immuni.2005.08.002
83. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005; 352:2598-608 PMID:15972866; http://dx.doi.org/10.1056/NEJMoa043980
84. Herold KC, Gitelman SE, Masharani U, Hagopian W, Bisikirska B, Donaldson D, Rother K, Diamond B, Harlan DM, Bluestone JA. A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 2005; 54:1763-9 PMID:15919798; http://dx.doi.org/10.2337/diabetes.54.6.1763
85. O’Neill SK, Liu E, Cambier JC. Change you can B(cell)eive in: recent progress confirms a critical role for B cells in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2009; 16:293-8 PMID:19502979; http://dx.doi.org/10.1097/MED.0b013e32832e06a7